England's vaccine inequality deepens as poorer children miss critical boosters

England's vaccine inequality deepens as poorer children miss critical boosters

Joshua Freeman
Joshua Freeman•
• 2 Min.
A doctor in a blue t-shirt and purple gloves administers a vaccine to a man's arm using a syringe, with medical equipment and papers visible in the background.

England's vaccine inequality deepens as poorer children miss critical boosters

A new study in The Lancet Regional Health – Europe reveals growing inequalities in childhood pneumococcal vaccine uptake across England. The research highlights a sharp decline in booster dose retention since a national immunisation schedule change in 2020. Children in poorer areas are now missing out more than ever, raising concerns about widening health gaps. The study analysed vaccination data from 2013 to 2025, covering periods before and after England's PCV schedule shifted from a '2+1' to a simpler '1+1' regimen. The change, introduced in January 2020, aimed to streamline immunisation while maintaining protection. However, retention of booster doses has since dropped, particularly in deprived communities.

While the COVID-19 pandemic disrupted healthcare access, the decline in uptake extends beyond temporary pandemic effects. Researchers stress that systemic barriers—rather than just schedule adjustments—are preventing equitable vaccine delivery. The most disadvantaged children now face higher risks of invasive diseases like pneumonia and meningitis due to missed boosters. The authors call for regular monitoring of booster uptake, broken down by deprivation and location. They argue that simplifying schedules alone is not enough. Instead, targeted outreach and flexible delivery options are needed to close the gap for marginalised groups.

The findings underscore an escalating public health challenge: immunisation inequality in England is deepening. Without intervention, vulnerable children will remain at greater risk of preventable pneumococcal infections. Policymakers now face pressure to address both structural barriers and the long-term consequences of uneven vaccine coverage.

Neueste Nachrichten